The short version
- What it doesBlood glucose is the most tightly governed variable a supplement on this shelf tries to move, and that governs what cinnamon can possibly do. Postprandial glucose is held by insulin secretion, hepatic glucose output, glucagon, incretins and renal threshold, all operating on a minute timescale.
- Who it is forBlood-sugar and post-meal glucose support.
- What to watchVery well tolerated — this is the safe cinnamon.
How Ceylon Cinnamon works
Cinnamon's glucose effect appears to run through several modest routes rather than one strong one: polyphenols that improve insulin receptor sensitivity, inhibition of intestinal disaccharidases which slows carbohydrate breakdown, and slowed gastric emptying. The far more important pharmacology here is what Ceylon lacks.
Read the rest of how it works
Cassia — the cheap cinnamon in most kitchens and most supplements — contains high levels of coumarin, which is hepatotoxic at sustained intake. Ceylon contains only trace amounts.
Ceylon Cinnamon: serving, timing and spacing
- Suggested serving
- 1–2 g Ceylon cinnamon daily.
- How often
- Daily
- When
- With carbohydrate-containing meals
- Spacing that matters for safety
- Use Ceylon, not cassia - cassia's coumarin is hepatotoxic in daily use
General referenceA general reference intake for education, not a prescription. The label on the product you buy is the final word.
Good to know: Use CEYLON, not cassia — cassia's high coumarin can stress the liver at supplement doses.
Research on Ceylon Cinnamon5 evidence notes: clinical, correlative, theoretical
Each note sits under the kind of evidence it stands on. A thin or missing trial means nobody has run it yet, not that it doesn’t work. How the evidence tiers work
Human clinical evidence
Meta-analyses show modest reductions in fasting glucose and improved insulin sensitivity.
Slows gastric emptying and post-meal glucose spikes.
Correlative data
Regular use tracks with better post-meal glucose in some studies.
Theoretical / extrapolated benefits
Cinnamaldehyde and the polyphenols appear to enhance insulin receptor signaling and slow gastric emptying, predicting a blunted post-meal glucose curve rather than a change in fasting glucose. The trial data broadly fits that shape.
The Ceylon-versus-cassia distinction is a coumarin argument, not an efficacy one: cassia contains far more coumarin, which is hepatotoxic at sustained intake. Ceylon is the safer vehicle for the same predicted effect.
Sources read for this page
- Moridpour AH. The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes mellitus: An updated systematic review and dose-response meta-analysis of randomized controlled trials. Phytother Res 2023 · PMID 37818728
- Zarezadeh M. The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes or with polycystic ovary syndrome: an umbrella meta-analysis on interventional meta-analyses. Diabetol Metab Syndr 2023 · PMID 37316893
- Pitaro M. Coumarin-Induced Hepatotoxicity: A Narrative Review. Molecules 2022 · PMID 36558195
- De Silva DAM. Clean vs dirty labels: Transparency and authenticity of the labels of Ceylon cinnamon. PLoS One 2021 · PMID 34813609
- Ghidotti M. High rate of safety and fraud issues in commercially available cinnamon. NPJ Sci Food 2025 · PMID 40617844
Ceylon Cinnamon, the deep readThe mechanism, cell to human, which form, how you would know
What Ceylon Cinnamon actually does
Blood glucose is the most tightly governed variable a supplement on this shelf tries to move, and that governs what cinnamon can possibly do. Postprandial glucose is held by insulin secretion, hepatic glucose output, glucagon, incretins and renal threshold, all operating on a minute timescale. A compound that nudges any one of them in a person whose loop is intact is met by the loop; the same nudge in a person whose beta cells or insulin sensitivity have already failed is not.
The proposed molecular actions are plausible and none of them is large. Cinnamon's A-type doubly linked procyanidin oligomers potentiate insulin receptor autophosphorylation in cell systems; cinnamaldehyde activates TRPA1 and has been linked to incretin release; and the whole extract slows gastric emptying, which flattens the postprandial curve without changing insulin sensitivity at all. That last mechanism would produce exactly the reported pattern -- a visible effect on postprandial glucose and a much smaller one on hemoglobin A1c.
The second controller on this page is hepatic and it decides safety rather than efficacy. Coumarin, abundant in cassia and present only in traces in Cinnamomum verum, is detoxified mainly by CYP2A6 7-hydroxylation. A minority route produces coumarin 3,4-epoxide, which is the hepatotoxic species, and the balance between the two routes is enzyme-capacity dependent Pitaro 2022. The tolerable daily intake for coumarin is 0.1 mg per kilogram of body weight, which for a 70 kilogram adult is 7 mg -- reachable from a couple of grams of cassia.
So the page has two set points and they point in opposite directions. The glycemic controller limits how much good the product can do. The hepatic enzyme controller decides how much harm the wrong species can do. Both are invisible on the label.
Cell, rodent, human — and where it stops
The human evidence is unusually well aggregated and it says one thing clearly: the effect scales with how far you start from normal.
What has been pooled. An updated systematic review and dose-response meta-analysis of randomized controlled trials covers glycemic control in type 2 diabetes Moridpour 2023, and an umbrella meta-analysis has since pooled the meta-analyses themselves across type 2 diabetes and polycystic ovary syndrome Zarezadeh 2023. Two layers of aggregation is more than most botanicals on this site have.
The specific obstacle is the recruited population. Both pooled analyses are built on trials in people with diagnosed metabolic disease Moridpour 2023 Zarezadeh 2023. A reader with a fasting glucose of 88 milligrams per deciliter is not the population studied, and the honest expectation for that reader is a change too small to distinguish from day-to-day variation.
The second obstacle is that most of those trials used cassia. The glycemic literature is dominated by Cinnamomum cassia because it is the cheap commodity, while the safe species is Cinnamomum verum. So the evidence for the effect and the argument for the safer form point at different plants, and no trial has compared them head to head at equal dose Pitaro 2022.
The third is that the label may not be true. Analysis of commercial cinnamon found a high rate of safety and authenticity problems Ghidotti 2025, and a dedicated study of Ceylon cinnamon labeling found transparency and authenticity failures in the products sold under that name De Silva 2021. A reader buying Ceylon to avoid coumarin is relying on a label that is measurably unreliable.
Ceylon Cinnamon — which form, and does it matter
Ceylon and cassia are two species and one aisle, and the difference is a hepatotoxin. Cinnamomum verum, true or Ceylon cinnamon, contains coumarin in traces. Cinnamomum cassia and its relatives contain it at levels that make a few grams a day a real exposure against a 0.1 mg per kilogram tolerable daily intake Pitaro 2022. Most supermarket cinnamon, and most cinnamon in cheap supplements, is cassia.
You can tell them apart by hand, which matters because the label sometimes cannot be trusted. Ceylon quills are made of many thin, fragile layers rolled together like a cigar and crumble under pressure. Cassia is a single thick, hard curl. Ground powder hides this, which is one reason the fraud is concentrated in powders De Silva 2021.
Whole spice, aqueous extract and ethanolic extract are three different chemistries. The procyanidins are water-soluble and concentrate in aqueous extracts; coumarin is more lipophilic and concentrates in alcoholic ones. An aqueous extract is therefore the form that keeps the proposed active and drops the toxin, and it is also the form least often sold.
The authenticity failure rate is the form question that overrides the others. A survey of commercially available cinnamon reported a high rate of safety and fraud issues Ghidotti 2025. Paying for Ceylon does not guarantee receiving it, which makes third-party species verification the only version of this product whose form claim is worth anything.
What would have to be true, and how you would know it was not
1. The postprandial prediction, and it is the one a reader can run this week. Continuous glucose monitoring or fingersticks at 30, 60 and 120 minutes after a fixed 75 gram carbohydrate meal, with and without 2 grams of cinnamon, each repeated three times. Predict a lower peak and a smaller area under the curve in someone whose peak exceeds 160 milligrams per deciliter, and nothing measurable in someone whose peak is 120 Moridpour 2023.
2. The hemoglobin A1c prediction, at 12 weeks. Predict a small fall, smaller than the postprandial data would lead you to expect, because a gastric-emptying mechanism moves peaks more than it moves averages Zarezadeh 2023. If hemoglobin A1c falls more than fasting glucose and postprandial glucose together justify, the mechanism is not the one described here.
3. The baseline-dependence prediction, which is the whole argument. Split responders by starting hemoglobin A1c. Predict the effect size falls toward zero as baseline approaches normal Zarezadeh 2023. If the effect is flat across baselines, the set point claim on this page is wrong.
4. The liver prediction, and it is a species test in disguise. Alanine aminotransferase and aspartate aminotransferase at baseline and 12 weeks on 3 or more grams a day. Predict no change on verified Ceylon and a possible rise on unverified powder, because the coumarin load is the variable Pitaro 2022 Ghidotti 2025.
5. The experiment that would settle the species argument. Cinnamomum verum against Cinnamomum cassia, matched grams, 12 weeks, hemoglobin A1c primary and liver enzymes secondary. Prediction: equal glycemic effect and unequal liver enzymes De Silva 2021. Nobody has run it, and it is the single study this category most needs.
What nobody has tested yet
Nobody has run the head-to-head species trial. The glycemic evidence sits mostly on cassia and the safety argument sits entirely on verum Moridpour 2023 Pitaro 2022, and the two have never been compared at equal dose in one protocol.
Nobody knows which molecule is responsible. Procyanidins, cinnamaldehyde and delayed gastric emptying are three candidate mechanisms and no trial has separated them by dosing purified fractions.
Nobody has established the coumarin content of retail supplements at scale. Fraud and safety issues have been documented in commercial cinnamon Ghidotti 2025 and labeling of Ceylon specifically has been examined De Silva 2021, and no ongoing surveillance reports milligrams of coumarin per daily serving on the products people actually buy.
And nobody has tested it in the population that buys it. Every pooled trial recruited people with metabolic disease. There is no adequately powered randomized trial of cinnamon in metabolically healthy adults, which means the effect in the majority of buyers is formally unknown rather than merely small Zarezadeh 2023.
Ceylon Cinnamon — its own safety story, not its category's
The hazard that belongs to this product rather than to its category is coumarin, and it is a species problem rather than a dose problem. Coumarin-induced hepatotoxicity is documented and the tolerable daily intake is 0.1 mg per kilogram of body weight Pitaro 2022. Verified Ceylon carries traces; cassia can put a 70 kilogram adult over that limit on a few grams.
The label is part of the hazard. Authenticity and safety problems are common in commercial cinnamon Ghidotti 2025, and products sold as Ceylon have been found to be inconsistently labeled De Silva 2021. Anyone taking grams a day for months should be buying species-verified product, not the cheapest jar with the right word on it.
The glucose interaction is pharmacological rather than theoretical. If the pooled glycemic effect is real Moridpour 2023, adding grams of cinnamon on top of insulin, a sulfonylurea or a glinide stacks two hypoglycemic stimuli. Anyone whose medication is titrated to their readings should tell the prescriber before starting, not after a low.
Liver disease changes the calculation entirely. The detoxifying route is hepatic Pitaro 2022, so anyone with established liver disease, heavy alcohol intake or a second hepatotoxic supplement in the cupboard is operating with less margin than the tolerable daily intake assumes.
Two smaller ones. Cinnamon has mild antiplatelet activity, which is additive with aspirin and anticoagulants; and high doses in pregnancy are best avoided given the uterine activity reported for several warming spices and the absence of controlled human data. Nothing here is medical advice, and none of these statements has been evaluated by the Food and Drug Administration.
Ceylon Cinnamon safety basics3 points of its own
Its own safety story
- Very well tolerated — this is the safe cinnamon.
- The reason to specify Ceylon: cassia cinnamon contains coumarin, which is hepatotoxic at sustained intake. Most supermarket cinnamon is cassia. Ceylon contains only trace amounts.
- Mild blood-glucose lowering; mild antiplatelet effect. Avoid high doses in pregnancy.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor. Pharmacists are underused and free.
Bloodwork to run3 tests in one order, code CAMERON
The tests that would show it working, and the ones that keep it safe: why each is here and when to recheck.
Code CAMERON applies automatically at checkout. Draw before you start, not after: a result with nothing to compare it to answers nothing.
Ceylon Cinnamon FAQ5 common questions
- What is Ceylon Cinnamon?
- The safe 'true' cinnamon (low coumarin) studied for blood-sugar and post-meal glucose control.
- What is the suggested dose of Ceylon Cinnamon?
- 1–2 g Ceylon cinnamon daily. This is a general reference for education only. Statements have not been evaluated by the FDA and this is not medical advice.
- Who is Ceylon Cinnamon for?
- Blood-sugar and post-meal glucose support.
- Which labs show whether Ceylon Cinnamon is doing anything?
- Comprehensive Metabolic Panel (CMP), HbA1c (Hemoglobin A1c), Fasting Insulin. Draw a baseline before you start, then recheck.
- Where can I buy Ceylon Cinnamon?
- Coach Cam sources Ceylon Cinnamon from vetted, top-rated brands on iHerb. Use the buy link on this page.



